Masseter corticomotor excitability is decreased after intramuscular administration of nerve growth factor

Abstract

Intramuscular administration of nerve growth factor into masseter muscle causes inhibitory corticomotor plasticity, which likely occurs to prevent further damage and seems associated with lower pain intensity on function.